These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38696854)

  • 1. Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models.
    Lin Y; Wang J; Li M; Zhou C; Hu Y; Wang M; Zhang X
    Breast; 2024 Aug; 76():103737. PubMed ID: 38696854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
    Wang J; Tian C; Zheng BJ; Zhang J; Jiao DC; Qu JR; Liu ZZ
    BMC Cancer; 2024 May; 24(1):549. PubMed ID: 38693523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.
    Wang SR; Cao CL; Du TT; Wang JL; Li J; Li WX; Chen M
    J Ultrasound Med; 2024 Sep; 43(9):1611-1625. PubMed ID: 38808580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
    Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
    Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Li Z; Ma Q; Gao Y; Qu M; Li J; Lei J
    Eur Radiol; 2024 Feb; 34(2):930-942. PubMed ID: 37615764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
    Wang L; Li Y; Li J; Wang T; Xie Y; He Y; Fan Z; Ouyang T
    Clin Transl Oncol; 2021 Feb; 23(2):240-245. PubMed ID: 32519177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
    Kim WH; Kim HJ; Park HY; Park JY; Chae YS; Lee SM; Cho SH; Shin KM; Lee SY
    Ultrasound Med Biol; 2019 Mar; 45(3):702-709. PubMed ID: 30567630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An MRI-based Scoring System for Preoperative Prediction of Axillary Response to Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: A Multicenter Retrospective Study.
    Huang X; Shi Z; Mai J; Liu C; Liu C; Chen S; Lu H; Li Y; He B; Li J; Cun H; Han C; Chen X; Liang C; Liu Z
    Acad Radiol; 2023 Jul; 30(7):1257-1269. PubMed ID: 36280517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography.
    Lee HJ; Nguyen AT; Song MW; Lee JE; Park SB; Jeong WG; Park MH; Lee JS; Park I; Lim HS
    Korean J Radiol; 2023 Jun; 24(6):498-511. PubMed ID: 37271204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing shear wave elastography of breast tumors and axillary nodes in the axillary assessment after neoadjuvant chemotherapy in patients with node-positive breast cancer.
    Huang JX; Liu FT; Sun L; Ma C; Fu J; Wang XY; Huang GL; Zhang YT; Pei XQ
    Radiol Med; 2024 Aug; 129(8):1143-1155. PubMed ID: 39060887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer.
    Huang JX; Lin SY; Ou Y; Shi CG; Zhong Y; Wei MJ; Pei XQ
    Eur Radiol; 2022 Sep; 32(9):5986-5996. PubMed ID: 35364714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.
    Ha SM; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
    Acta Radiol; 2017 Oct; 58(10):1198-1205. PubMed ID: 28350255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting axillary lymph node metastasis in breast cancer patients: A radiomics-based multicenter approach with interpretability analysis.
    Liu Z; Hong M; Li X; Lin L; Tan X; Liu Y
    Eur J Radiol; 2024 Jul; 176():111522. PubMed ID: 38805883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial.
    Zhu T; Huang YH; Li W; Wu CG; Zhang YM; Zheng XX; Zhang TF; Lin YY; Liu ZY; Ye GL; Lin Y; Wu ZY; Wang K
    Br J Cancer; 2024 Sep; 131(4):692-701. PubMed ID: 38918556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study.
    Zhu T; Huang YH; Li W; Zhang YM; Lin YY; Cheng MY; Wu ZY; Ye GL; Lin Y; Wang K
    Int J Surg; 2023 Nov; 109(11):3383-3394. PubMed ID: 37830943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
    Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS
    Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cutting-edge deep learning-and-radiomics-based ultrasound nomogram for precise prediction of axillary lymph node metastasis in breast cancer patients ≥ 75 years.
    Qian L; Liu X; Zhou S; Zhi W; Zhang K; Li H; Li J; Chang C
    Front Endocrinol (Lausanne); 2024; 15():1323452. PubMed ID: 39072273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.